As of 2026-03-25, the Relative Valuation of agilon health Inc (AGL) is (13.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.44 USD, the upside of agilon health Inc based on Relative Valuation is -3060.3%.
The range of the Relative Valuation is (12.26) - (13.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 22.3x | 20.5x |
| Forward P/E multiples | 15.1x - 20.2x | 18.2x |
| Fair Price | (12.26) - (13.60) | (13.02) |
| Upside | -2886.9% - -3192.4% | -3060.3% |
| Date | P/E |
| 2026-03-24 | -0.65 |
| 2026-03-23 | -0.65 |
| 2026-03-20 | -0.63 |
| 2026-03-19 | -0.70 |
| 2026-03-18 | -0.88 |
| 2026-03-17 | -0.91 |
| 2026-03-16 | -0.89 |
| 2026-03-13 | -0.89 |
| 2026-03-12 | -0.90 |
| 2026-03-11 | -0.95 |
| 2026-03-10 | -0.87 |
| 2026-03-09 | -0.89 |
| 2026-03-06 | -0.89 |
| 2026-03-05 | -0.99 |
| 2026-03-04 | -1.04 |
| 2026-03-03 | -0.84 |
| 2026-03-02 | -0.92 |
| 2026-02-27 | -0.88 |
| 2026-02-26 | -0.88 |
| 2026-02-25 | -0.74 |
| 2026-02-24 | -0.59 |
| 2026-02-23 | -0.65 |
| 2026-02-20 | -0.65 |
| 2026-02-19 | -0.60 |
| 2026-02-18 | -0.56 |
| 2026-02-17 | -0.53 |
| 2026-02-13 | -0.54 |
| 2026-02-12 | -0.54 |
| 2026-02-11 | -0.57 |
| 2026-02-10 | -0.67 |
| 2026-02-09 | -0.92 |
| 2026-02-06 | -0.96 |
| 2026-02-05 | -0.94 |
| 2026-02-04 | -1.03 |
| 2026-02-03 | -1.14 |
| 2026-02-02 | -1.23 |
| 2026-01-30 | -1.24 |
| 2026-01-29 | -1.28 |
| 2026-01-28 | -1.22 |
| 2026-01-27 | -1.27 |
| 2026-01-26 | -1.41 |
| 2026-01-23 | -1.47 |
| 2026-01-22 | -1.50 |
| 2026-01-21 | -1.42 |
| 2026-01-20 | -1.45 |
| 2026-01-16 | -1.52 |
| 2026-01-15 | -1.52 |
| 2026-01-14 | -1.44 |
| 2026-01-13 | -1.41 |
| 2026-01-12 | -1.47 |